(Q37822760)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174625%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

review article

1 reference

title

Pharmacometabonomics as an effector for personalized medicine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174625%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

main subject

personalized medicine

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174625%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ian Wilson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174625%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

John C Lindon

3

0 references

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174625%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174625%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174625%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

103-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174625%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174625%20AND%20SRC:MED&resulttype=core&format=json

Pharmaco-metabonomic phenotyping and personalized drug treatment

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Gut microorganisms, mammalian metabolism and personalized health care

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Analytical strategies in metabonomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

The application of microbore UPLC/oa-TOF-MS and 1H NMR spectroscopy to the metabonomic analysis of rat urine following the intravenous administration of pravastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

A prospective study of transsulfuration biomarkers in autistic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Serum molecular signatures of weight change during early breast cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Human metabolic phenotype diversity and its association with diet and blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Symbiotic gut microbes modulate human metabolic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Personalized therapy and pharmacogenomics: future perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

Pattern recognition methods and applications in biomedical magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.157

21 January 2018

Identifiers

DOI

10.2217/PGS.10.157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21174625%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference